Primary Headache in Yemen: Prevalence and Common Medications Used

الملخص EN

Background and Objective.

Primary headaches is a major medical concern in certain Arabic countries, for example Oman, Jordan, and Qatar.

This study was aimed at increasing understanding of the prevalence of headache in Arabic countries and identifying common medications used for treatment because of the lack of research done in this field in Yemen.

Methods.

This is a cross-sectional observational study conducted by recruiting case-series of adults and elderly who have primary headache within the age group from 18 to 85 years.

12640 subjects received a simple explanation for the aim of the study as ethical issue.

The subjects were allowed to complete a self-conducted screening questionnaire.

The data were diagnosed according to the International Headache Society’s diagnostic criteria (2004).

Results.

The results showed that 76.5% of the primary headache is prevalent at least once per year, 27.1% of the tension type headache (TTH) was the maximum percentage of type of headache, and 14.48% of the migraine headache (MH) was the minimum percentage.

On the other hand, the relationship between the primary headache and age of subjects was statistically significant (P<0.05), while between primary headache and sex was not (P>0.05).

In addition, 70.15% of the subjects said that headache attacks affected their activity of daily livings (ADL).

62.26% of the subjects used the medications without medical advice regarding their headache.

37.73% of the subjects relied on medical professionals (physicians and pharmacist) regarding analgesics use.

The most common agent used among the medications was paracetamol (38.4%).

Others included ibuprofen, aspirin, diclofenac sodium, naproxen, mefenamic acid, ergotamine and (11.45%) were unknown agents.

Conclusion.

We concluded that absence of health attention from the Yemeni Community and education from the health system in the country regarding analgesics use and their potential risk led to abuse of such medications and could be a reason beyond high prevalence of headache in Yemen.